

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.28167018 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.28167018 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.57152585 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.52565259 |
| 5 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.30963034 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.96463139 |
| 7 | regulation of gamma-delta T cell activation (GO:0046643) | 4.77610277 |
| 8 | T cell migration (GO:0072678) | 4.56319268 |
| 9 | negative regulation of interleukin-12 production (GO:0032695) | 4.47788615 |
| 10 | * response to type I interferon (GO:0034340) | 4.44947283 |
| 11 | * cellular response to type I interferon (GO:0071357) | 4.43753347 |
| 12 | * type I interferon signaling pathway (GO:0060337) | 4.43753347 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.42739721 |
| 14 | NIK/NF-kappaB signaling (GO:0038061) | 4.37871796 |
| 15 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.33253572 |
| 16 | response to interleukin-15 (GO:0070672) | 4.32123065 |
| 17 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.30762875 |
| 18 | negative T cell selection (GO:0043383) | 4.26586764 |
| 19 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.26103926 |
| 20 | regulation of vitamin metabolic process (GO:0030656) | 4.25413165 |
| 21 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.19799288 |
| 22 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.19596403 |
| 23 | negative thymic T cell selection (GO:0045060) | 4.13376668 |
| 24 | leukocyte aggregation (GO:0070486) | 4.11716772 |
| 25 | positive thymic T cell selection (GO:0045059) | 4.11677591 |
| 26 | cellular response to interleukin-15 (GO:0071350) | 4.10743744 |
| 27 | interferon-gamma production (GO:0032609) | 4.07926868 |
| 28 | tolerance induction (GO:0002507) | 3.99395156 |
| 29 | positive regulation of type 2 immune response (GO:0002830) | 3.88796717 |
| 30 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.88686738 |
| 31 | thymic T cell selection (GO:0045061) | 3.88316092 |
| 32 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.86343616 |
| 33 | negative regulation of cell killing (GO:0031342) | 3.86343616 |
| 34 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.78373647 |
| 35 | T cell selection (GO:0045058) | 3.76652795 |
| 36 | defense response to protozoan (GO:0042832) | 3.74885717 |
| 37 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.74701274 |
| 38 | germinal center formation (GO:0002467) | 3.72215725 |
| 39 | negative regulation of viral genome replication (GO:0045071) | 3.70883030 |
| 40 | * regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.69526946 |
| 41 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.69147520 |
| 42 | positive regulation of heat generation (GO:0031652) | 3.67448606 |
| 43 | immunoglobulin mediated immune response (GO:0016064) | 3.66859432 |
| 44 | regulation of fever generation (GO:0031620) | 3.65216042 |
| 45 | T-helper 1 type immune response (GO:0042088) | 3.63846828 |
| 46 | positive T cell selection (GO:0043368) | 3.61322628 |
| 47 | regulation of immunoglobulin secretion (GO:0051023) | 3.57437117 |
| 48 | myeloid dendritic cell differentiation (GO:0043011) | 3.56629219 |
| 49 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.54275309 |
| 50 | response to protozoan (GO:0001562) | 3.53880283 |
| 51 | regulation of podosome assembly (GO:0071801) | 3.53057788 |
| 52 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.50305503 |
| 53 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 3.45076488 |
| 54 | T cell receptor signaling pathway (GO:0050852) | 3.43373106 |
| 55 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.42934090 |
| 56 | positive regulation of interferon-alpha production (GO:0032727) | 3.42634990 |
| 57 | activation of MAPKKK activity (GO:0000185) | 3.40241240 |
| 58 | * JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.39064750 |
| 59 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.38798692 |
| 60 | modulation by symbiont of host defense response (GO:0052031) | 3.37235046 |
| 61 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.37235046 |
| 62 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.37235046 |
| 63 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.37235046 |
| 64 | modulation by symbiont of host immune response (GO:0052553) | 3.37235046 |
| 65 | positive regulation by symbiont of host defense response (GO:0052509) | 3.37235046 |
| 66 | lymphocyte costimulation (GO:0031294) | 3.36913458 |
| 67 | positive regulation of isotype switching (GO:0045830) | 3.36441745 |
| 68 | myeloid dendritic cell activation (GO:0001773) | 3.34150591 |
| 69 | regulation of interleukin-12 production (GO:0032655) | 3.33929978 |
| 70 | T cell costimulation (GO:0031295) | 3.33828744 |
| 71 | dendritic cell differentiation (GO:0097028) | 3.33109545 |
| 72 | positive regulation of interleukin-2 production (GO:0032743) | 3.32111076 |
| 73 | regulation of interferon-alpha production (GO:0032647) | 3.32080034 |
| 74 | regulation of antigen processing and presentation (GO:0002577) | 3.31254997 |
| 75 | macrophage activation involved in immune response (GO:0002281) | 3.31205881 |
| 76 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.30663632 |
| 77 | positive regulation of antigen processing and presentation (GO:0002579) | 3.29019110 |
| 78 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.28981877 |
| 79 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.27549955 |
| 80 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.27298658 |
| 81 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.26502551 |
| 82 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.20582806 |
| 83 | positive regulation of B cell mediated immunity (GO:0002714) | 3.20582806 |
| 84 | * regulation of response to interferon-gamma (GO:0060330) | 3.19791488 |
| 85 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.19232735 |
| 86 | cellular response to interferon-beta (GO:0035458) | 3.18485550 |
| 87 | regulation of type 2 immune response (GO:0002828) | 3.17957893 |
| 88 | response to muramyl dipeptide (GO:0032495) | 3.14375757 |
| 89 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.11395302 |
| 90 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.10570120 |
| 91 | T-helper cell differentiation (GO:0042093) | 3.10570120 |
| 92 | positive regulation of defense response to virus by host (GO:0002230) | 3.10436777 |
| 93 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.10201036 |
| 94 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.09514321 |
| 95 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.08907959 |
| 96 | * cellular response to interferon-gamma (GO:0071346) | 3.08276689 |
| 97 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.07168877 |
| 98 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.07005539 |
| 99 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.06490137 |
| 100 | cellular response to virus (GO:0098586) | 3.06304180 |
| 101 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.06224595 |
| 102 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.06095908 |
| 103 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.05841789 |
| 104 | * regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.04992703 |
| 105 | alpha-beta T cell activation (GO:0046631) | 3.04794104 |
| 106 | lymphocyte chemotaxis (GO:0048247) | 3.04405918 |
| 107 | B cell mediated immunity (GO:0019724) | 3.04319884 |
| 108 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.03306529 |
| 109 | positive regulation of interleukin-12 production (GO:0032735) | 3.03294491 |
| 110 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.02941847 |
| 111 | positive regulation of humoral immune response (GO:0002922) | 3.02775750 |
| 112 | natural killer cell activation (GO:0030101) | 3.02407463 |
| 113 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.02070145 |
| 114 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.01796909 |
| 115 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.01720468 |
| 116 | natural killer cell differentiation (GO:0001779) | 2.99041186 |
| 117 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.97216067 |
| 118 | regulation of T cell tolerance induction (GO:0002664) | 2.96408734 |
| 119 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.96110379 |
| 120 | response to interferon-alpha (GO:0035455) | 2.95338984 |
| 121 | alpha-beta T cell differentiation (GO:0046632) | 2.93746963 |
| 122 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.93600325 |
| 123 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.93448155 |
| 124 | * response to interferon-gamma (GO:0034341) | 2.92962825 |
| 125 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.92411395 |
| 126 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.92406980 |
| 127 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.91251644 |
| 128 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.90529638 |
| 129 | positive regulation of interferon-beta production (GO:0032728) | 2.89827433 |
| 130 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.89608884 |
| 131 | cellular response to interferon-alpha (GO:0035457) | 2.89418785 |
| 132 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.89119169 |
| 133 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.88198372 |
| 134 | positive regulation of interleukin-17 production (GO:0032740) | 2.88170817 |
| 135 | positive regulation of macrophage differentiation (GO:0045651) | 2.88151647 |
| 136 | response to interferon-beta (GO:0035456) | 2.87965283 |
| 137 | response to peptidoglycan (GO:0032494) | 2.87738948 |
| 138 | negative regulation of T cell mediated immunity (GO:0002710) | 2.87301319 |
| 139 | lymphocyte migration (GO:0072676) | 2.86854848 |
| 140 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.86661714 |
| 141 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.86661714 |
| 142 | T cell differentiation involved in immune response (GO:0002292) | 2.86661714 |
| 143 | regulation of RIG-I signaling pathway (GO:0039535) | 2.86122602 |
| 144 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.85210662 |
| 145 | regulation of T-helper 1 type immune response (GO:0002825) | 2.84935040 |
| 146 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.84832458 |
| 147 | negative regulation of type I interferon production (GO:0032480) | 2.84600552 |
| 148 | regulation of T-helper cell differentiation (GO:0045622) | 2.84589293 |
| 149 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.84355723 |
| 150 | positive regulation of DNA recombination (GO:0045911) | 2.84269626 |
| 151 | regulation of chemokine biosynthetic process (GO:0045073) | 2.84130983 |
| 152 | regulation of chronic inflammatory response (GO:0002676) | 2.83946542 |
| 153 | cellular response to lipopolysaccharide (GO:0071222) | 2.83707622 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.30699006 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.13370447 |
| 3 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.33888230 |
| 4 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.14279416 |
| 5 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.99599599 |
| 6 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.92341921 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.60542249 |
| 8 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.28426944 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.19990238 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.19616157 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.94817600 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.93142347 |
| 13 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.90059388 |
| 14 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.84346867 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.71989735 |
| 16 | MYB_26560356_Chip-Seq_TH2_Human | 2.64159321 |
| 17 | * MAF_26560356_Chip-Seq_TH1_Human | 2.56850543 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.54102987 |
| 19 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.42470112 |
| 20 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.41474089 |
| 21 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.41043306 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.38406243 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.36735763 |
| 24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.27686122 |
| 25 | UTX_26944678_Chip-Seq_JUKART_Human | 2.23167730 |
| 26 | * MYB_26560356_Chip-Seq_TH1_Human | 2.19678637 |
| 27 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.19306528 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.98209545 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.97799511 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96682410 |
| 31 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.94859330 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.90670725 |
| 33 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.89800396 |
| 34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.88422917 |
| 35 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.84599799 |
| 36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.82561359 |
| 37 | MAF_26560356_Chip-Seq_TH2_Human | 1.79797675 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.75390575 |
| 39 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.72194507 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.65240977 |
| 41 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.60849322 |
| 42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.60552471 |
| 43 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.59013832 |
| 44 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.58693634 |
| 45 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.56538747 |
| 46 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55697294 |
| 47 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.54159859 |
| 48 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.53939944 |
| 49 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.53379972 |
| 50 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45409722 |
| 51 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.44533041 |
| 52 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.42502138 |
| 53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41174206 |
| 54 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.40061176 |
| 55 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.34998930 |
| 56 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33303226 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.31186242 |
| 58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.30146290 |
| 59 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27041633 |
| 60 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.23979387 |
| 61 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.21651101 |
| 62 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21113227 |
| 63 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16662225 |
| 64 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15385614 |
| 65 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15205760 |
| 66 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14811231 |
| 67 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.14509178 |
| 68 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13522313 |
| 69 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04394495 |
| 70 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04014099 |
| 71 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.03279222 |
| 72 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03009074 |
| 73 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.02773940 |
| 74 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.01586377 |
| 75 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.01248486 |
| 76 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01185153 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00614901 |
| 78 | GATA1_22025678_ChIP-Seq_K562_Human | 0.99212855 |
| 79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98547912 |
| 80 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96601551 |
| 81 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96591077 |
| 82 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.96394344 |
| 83 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.95911514 |
| 84 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.95755460 |
| 85 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.95673394 |
| 86 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.95041625 |
| 87 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.94846631 |
| 88 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.94846631 |
| 89 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.94846631 |
| 90 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.94405483 |
| 91 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.93487312 |
| 92 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92351076 |
| 93 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91569503 |
| 94 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.90714500 |
| 95 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.90200885 |
| 96 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89821477 |
| 97 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89148222 |
| 98 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.88951297 |
| 99 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.88839313 |
| 100 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.87958730 |
| 101 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.87521177 |
| 102 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87219974 |
| 103 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.86962603 |
| 104 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.85681935 |
| 105 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.85112043 |
| 106 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84133250 |
| 107 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.80556433 |
| 108 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.80531710 |
| 109 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.79517102 |
| 110 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.79111956 |
| 111 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.78841367 |
| 112 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77962364 |
| 113 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.77863585 |
| 114 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.77690306 |
| 115 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77537852 |
| 116 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75667085 |
| 117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.69940836 |
| 118 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.69679520 |
| 119 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.69537283 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.03365483 |
| 2 | MP0005671_abnormal_response_to | 3.71032210 |
| 3 | MP0000685_abnormal_immune_system | 3.66968098 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.48421818 |
| 5 | MP0003436_decreased_susceptibility_to | 3.34710866 |
| 6 | MP0001790_abnormal_immune_system | 3.30253898 |
| 7 | MP0005387_immune_system_phenotype | 3.30253898 |
| 8 | * MP0009785_altered_susceptibility_to | 3.27599729 |
| 9 | MP0006082_CNS_inflammation | 3.25847273 |
| 10 | MP0001800_abnormal_humoral_immune | 3.10818290 |
| 11 | * MP0005000_abnormal_immune_tolerance | 3.08354051 |
| 12 | MP0003303_peritoneal_inflammation | 3.04488641 |
| 13 | * MP0002723_abnormal_immune_serum | 2.77320505 |
| 14 | * MP0005025_abnormal_response_to | 2.76044071 |
| 15 | MP0003724_increased_susceptibility_to | 2.70304736 |
| 16 | * MP0002452_abnormal_antigen_presenting | 2.69549271 |
| 17 | * MP0001819_abnormal_immune_cell | 2.58038095 |
| 18 | * MP0002420_abnormal_adaptive_immunity | 2.57235037 |
| 19 | MP0009333_abnormal_splenocyte_physiolog | 2.50893760 |
| 20 | MP0002166_altered_tumor_susceptibility | 2.46429946 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.42976352 |
| 22 | MP0002405_respiratory_system_inflammati | 2.42961112 |
| 23 | * MP0002398_abnormal_bone_marrow | 2.42410092 |
| 24 | MP0005451_abnormal_body_composition | 2.27366311 |
| 25 | MP0002006_tumorigenesis | 2.25558415 |
| 26 | * MP0002419_abnormal_innate_immunity | 2.25174743 |
| 27 | * MP0000716_abnormal_immune_system | 2.18309106 |
| 28 | * MP0010155_abnormal_intestine_physiology | 2.15450444 |
| 29 | * MP0004947_skin_inflammation | 2.15034171 |
| 30 | MP0003300_gastrointestinal_ulcer | 2.05030012 |
| 31 | * MP0002722_abnormal_immune_system | 1.96564545 |
| 32 | MP0002139_abnormal_hepatobiliary_system | 1.95358770 |
| 33 | MP0001873_stomach_inflammation | 1.92224371 |
| 34 | * MP0000703_abnormal_thymus_morphology | 1.90077908 |
| 35 | * MP0000689_abnormal_spleen_morphology | 1.87158352 |
| 36 | MP0004808_abnormal_hematopoietic_stem | 1.86802389 |
| 37 | * MP0001845_abnormal_inflammatory_respons | 1.83718037 |
| 38 | * MP0002429_abnormal_blood_cell | 1.79780676 |
| 39 | MP0001533_abnormal_skeleton_physiology | 1.78663777 |
| 40 | * MP0004510_myositis | 1.77062355 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.72996458 |
| 42 | MP0009278_abnormal_bone_marrow | 1.72161122 |
| 43 | MP0003866_abnormal_defecation | 1.69421712 |
| 44 | MP0008004_abnormal_stomach_pH | 1.67964726 |
| 45 | MP0002396_abnormal_hematopoietic_system | 1.65946559 |
| 46 | MP0003448_altered_tumor_morphology | 1.58363622 |
| 47 | * MP0005310_abnormal_salivary_gland | 1.57173289 |
| 48 | MP0002933_joint_inflammation | 1.52451435 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.45553404 |
| 50 | MP0001545_abnormal_hematopoietic_system | 1.45553404 |
| 51 | * MP0008469_abnormal_protein_level | 1.37149084 |
| 52 | MP0010352_gastrointestinal_tract_polyps | 1.35797437 |
| 53 | MP0000858_altered_metastatic_potential | 1.35086578 |
| 54 | MP0002332_abnormal_exercise_endurance | 1.33939026 |
| 55 | MP0010307_abnormal_tumor_latency | 1.33829699 |
| 56 | * MP0001853_heart_inflammation | 1.28629215 |
| 57 | MP0005076_abnormal_cell_differentiation | 1.26364241 |
| 58 | MP0001348_abnormal_lacrimal_gland | 1.21656643 |
| 59 | MP0002998_abnormal_bone_remodeling | 1.20038260 |
| 60 | MP0000490_abnormal_crypts_of | 1.15016412 |
| 61 | MP0009840_abnormal_foam_cell | 1.14392416 |
| 62 | MP0009764_decreased_sensitivity_to | 1.10904502 |
| 63 | MP0005167_abnormal_blood-brain_barrier | 1.10379143 |
| 64 | MP0002138_abnormal_hepatobiliary_system | 1.02862124 |
| 65 | MP0006054_spinal_hemorrhage | 1.02510612 |
| 66 | MP0000343_altered_response_to | 0.98880584 |
| 67 | MP0005023_abnormal_wound_healing | 0.97285439 |
| 68 | MP0003806_abnormal_nucleotide_metabolis | 0.96387621 |
| 69 | * MP0002019_abnormal_tumor_incidence | 0.95233594 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 0.94879190 |
| 71 | MP0001542_abnormal_bone_strength | 0.93669025 |
| 72 | MP0005058_abnormal_lysosome_morphology | 0.89602330 |
| 73 | MP0005390_skeleton_phenotype | 0.88133444 |
| 74 | MP0003453_abnormal_keratinocyte_physiol | 0.85365762 |
| 75 | MP0005166_decreased_susceptibility_to | 0.84547827 |
| 76 | * MP0001851_eye_inflammation | 0.84228929 |
| 77 | MP0003693_abnormal_embryo_hatching | 0.80290092 |
| 78 | MP0003195_calcinosis | 0.80194699 |
| 79 | MP0001501_abnormal_sleep_pattern | 0.79386781 |
| 80 | MP0003690_abnormal_glial_cell | 0.76261694 |
| 81 | MP0000604_amyloidosis | 0.75471773 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 0.75460371 |
| 83 | MP0005666_abnormal_adipose_tissue | 0.75165189 |
| 84 | MP0004381_abnormal_hair_follicle | 0.74759830 |
| 85 | MP0002277_abnormal_respiratory_mucosa | 0.74279812 |
| 86 | MP0003045_fibrosis | 0.73985242 |
| 87 | * MP0009763_increased_sensitivity_to | 0.72250677 |
| 88 | MP0008874_decreased_physiological_sensi | 0.70704931 |
| 89 | MP0003077_abnormal_cell_cycle | 0.70330611 |
| 90 | MP0003191_abnormal_cellular_cholesterol | 0.69379556 |
| 91 | MP0003795_abnormal_bone_structure | 0.68456335 |
| 92 | MP0000249_abnormal_blood_vessel | 0.66678738 |
| 93 | MP0002132_abnormal_respiratory_system | 0.65444291 |
| 94 | MP0003566_abnormal_cell_adhesion | 0.62380729 |
| 95 | MP0002254_reproductive_system_inflammat | 0.61847856 |
| 96 | MP0001663_abnormal_digestive_system | 0.60751315 |
| 97 | MP0003172_abnormal_lysosome_physiology | 0.60433224 |
| 98 | MP0005410_abnormal_fertilization | 0.59643387 |
| 99 | MP0005535_abnormal_body_temperature | 0.58900934 |
| 100 | MP0003091_abnormal_cell_migration | 0.57662980 |
| 101 | MP0005647_abnormal_sex_gland | 0.57358568 |
| 102 | MP0008260_abnormal_autophagy | 0.57116061 |
| 103 | MP0003075_altered_response_to | 0.56315184 |
| 104 | MP0000313_abnormal_cell_death | 0.55531268 |
| 105 | MP0005381_digestive/alimentary_phenotyp | 0.55482085 |
| 106 | MP0000477_abnormal_intestine_morphology | 0.54745780 |
| 107 | MP0003646_muscle_fatigue | 0.54518780 |
| 108 | MP0001881_abnormal_mammary_gland | 0.53247062 |
| 109 | MP0008007_abnormal_cellular_replicative | 0.53094872 |
| 110 | * MP0002693_abnormal_pancreas_physiology | 0.52576625 |
| 111 | MP0005174_abnormal_tail_pigmentation | 0.51385502 |
| 112 | MP0004883_abnormal_blood_vessel | 0.49866635 |
| 113 | MP0001727_abnormal_embryo_implantation | 0.49446049 |
| 114 | MP0008057_abnormal_DNA_replication | 0.48697975 |
| 115 | MP0003111_abnormal_nucleus_morphology | 0.48568399 |
| 116 | MP0000627_abnormal_mammary_gland | 0.47314461 |
| 117 | * MP0002136_abnormal_kidney_physiology | 0.47044383 |
| 118 | * MP0000609_abnormal_liver_physiology | 0.46889450 |
| 119 | MP0005075_abnormal_melanosome_morpholog | 0.46760295 |
| 120 | MP0001191_abnormal_skin_condition | 0.44946501 |
| 121 | MP0001243_abnormal_dermal_layer | 0.44664686 |
| 122 | MP0008873_increased_physiological_sensi | 0.44195183 |
| 123 | * MP0009765_abnormal_xenobiotic_induced | 0.43366871 |
| 124 | MP0005164_abnormal_response_to | 0.42677766 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.72319084 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.48053316 |
| 3 | Nasal polyposis (HP:0100582) | 5.02273247 |
| 4 | Recurrent fungal infections (HP:0002841) | 4.86748779 |
| 5 | T lymphocytopenia (HP:0005403) | 4.84181646 |
| 6 | Abnormality of T cell number (HP:0011839) | 4.80269572 |
| 7 | Chronic otitis media (HP:0000389) | 4.76401003 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 4.70786801 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.70786801 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.70786801 |
| 11 | Myositis (HP:0100614) | 4.62368564 |
| 12 | Stomatitis (HP:0010280) | 4.56353236 |
| 13 | Recurrent bronchitis (HP:0002837) | 4.49413831 |
| 14 | Severe combined immunodeficiency (HP:0004430) | 4.46136940 |
| 15 | Recurrent viral infections (HP:0004429) | 4.40832569 |
| 16 | Abnormality of the nasal mucosa (HP:0000433) | 4.35384161 |
| 17 | Systemic lupus erythematosus (HP:0002725) | 4.27181444 |
| 18 | Recurrent abscess formation (HP:0002722) | 4.23112470 |
| 19 | Abnormality of T cells (HP:0002843) | 4.18417357 |
| 20 | Combined immunodeficiency (HP:0005387) | 4.03770152 |
| 21 | Orchitis (HP:0100796) | 4.02645222 |
| 22 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.98269406 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 3.98269406 |
| 24 | Optic neuritis (HP:0100653) | 3.85622489 |
| 25 | Retrobulbar optic neuritis (HP:0100654) | 3.85622489 |
| 26 | Mediastinal lymphadenopathy (HP:0100721) | 3.82133819 |
| 27 | Increased IgM level (HP:0003496) | 3.72691003 |
| 28 | Recurrent bacterial skin infections (HP:0005406) | 3.70164504 |
| 29 | B lymphocytopenia (HP:0010976) | 3.66999063 |
| 30 | Abnormality of B cell number (HP:0010975) | 3.66999063 |
| 31 | Vacuolated lymphocytes (HP:0001922) | 3.66243118 |
| 32 | Loss of speech (HP:0002371) | 3.64422912 |
| 33 | IgM deficiency (HP:0002850) | 3.61203052 |
| 34 | Vasculitis (HP:0002633) | 3.57688387 |
| 35 | Panhypogammaglobulinemia (HP:0003139) | 3.56371094 |
| 36 | Autoimmune thrombocytopenia (HP:0001973) | 3.52166110 |
| 37 | IgG deficiency (HP:0004315) | 3.51999804 |
| 38 | Abnormality of T cell physiology (HP:0011840) | 3.43971857 |
| 39 | Thyroiditis (HP:0100646) | 3.42749958 |
| 40 | Abnormality of eosinophils (HP:0001879) | 3.39763402 |
| 41 | Dysostosis multiplex (HP:0000943) | 3.37933394 |
| 42 | Leukocytosis (HP:0001974) | 3.35094707 |
| 43 | Recurrent skin infections (HP:0001581) | 3.31064376 |
| 44 | Abnormality of macrophages (HP:0004311) | 3.22421998 |
| 45 | Eosinophilia (HP:0001880) | 3.22360320 |
| 46 | Pustule (HP:0200039) | 3.22121006 |
| 47 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.22010768 |
| 48 | Gangrene (HP:0100758) | 3.04884053 |
| 49 | Chronic obstructive pulmonary disease (HP:0006510) | 3.01817350 |
| 50 | Obstructive lung disease (HP:0006536) | 3.01817350 |
| 51 | Meningitis (HP:0001287) | 2.99366581 |
| 52 | Autoimmune hemolytic anemia (HP:0001890) | 2.97663896 |
| 53 | Hypergammaglobulinemia (HP:0010702) | 2.97398733 |
| 54 | Increased IgE level (HP:0003212) | 2.97033030 |
| 55 | Pulmonary infiltrates (HP:0002113) | 2.92535635 |
| 56 | Lymphopenia (HP:0001888) | 2.90648915 |
| 57 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.88258866 |
| 58 | Disinhibition (HP:0000734) | 2.85428659 |
| 59 | Granulocytopenia (HP:0001913) | 2.83716392 |
| 60 | Gastrointestinal infarctions (HP:0005244) | 2.80305581 |
| 61 | Nuclear cataract (HP:0100018) | 2.77909226 |
| 62 | Increased density of long bones (HP:0006392) | 2.77553524 |
| 63 | Petechiae (HP:0000967) | 2.76122221 |
| 64 | Hemoptysis (HP:0002105) | 2.75720219 |
| 65 | IgA deficiency (HP:0002720) | 2.72292863 |
| 66 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.71789000 |
| 67 | Chronic diarrhea (HP:0002028) | 2.69260263 |
| 68 | Cellulitis (HP:0100658) | 2.65166751 |
| 69 | Gingivitis (HP:0000230) | 2.62967085 |
| 70 | Arterial thrombosis (HP:0004420) | 2.62565128 |
| 71 | Increased serum ferritin (HP:0003281) | 2.61110293 |
| 72 | Emphysema (HP:0002097) | 2.60535971 |
| 73 | Parakeratosis (HP:0001036) | 2.52147179 |
| 74 | Chronic sinusitis (HP:0011109) | 2.51555198 |
| 75 | Interstitial pulmonary disease (HP:0006530) | 2.49842620 |
| 76 | Joint swelling (HP:0001386) | 2.49586334 |
| 77 | Abnormality of the fingertips (HP:0001211) | 2.48796081 |
| 78 | Lymphoma (HP:0002665) | 2.48293921 |
| 79 | Progressive neurologic deterioration (HP:0002344) | 2.47176179 |
| 80 | Glomerulonephritis (HP:0000099) | 2.45642224 |
| 81 | Keratoconjunctivitis sicca (HP:0001097) | 2.45518026 |
| 82 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.45315388 |
| 83 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.45315388 |
| 84 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.45315388 |
| 85 | Inflammation of the large intestine (HP:0002037) | 2.44725897 |
| 86 | Bronchitis (HP:0012387) | 2.43828201 |
| 87 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.43551299 |
| 88 | Basal ganglia calcification (HP:0002135) | 2.42679305 |
| 89 | Gastrointestinal inflammation (HP:0004386) | 2.41504464 |
| 90 | Mutism (HP:0002300) | 2.38780889 |
| 91 | Keratoconjunctivitis (HP:0001096) | 2.36886067 |
| 92 | Thrombocytosis (HP:0001894) | 2.34026725 |
| 93 | Polyneuropathy (HP:0001271) | 2.32883977 |
| 94 | Spontaneous hematomas (HP:0007420) | 2.32120336 |
| 95 | Mucopolysacchariduria (HP:0008155) | 2.32044374 |
| 96 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.32044374 |
| 97 | Gastrointestinal stroma tumor (HP:0100723) | 2.26753830 |
| 98 | Cheilitis (HP:0100825) | 2.26475313 |
| 99 | Hypoplasia of the thymus (HP:0000778) | 2.25822967 |
| 100 | Gingival bleeding (HP:0000225) | 2.24866168 |
| 101 | Anorexia (HP:0002039) | 2.22379183 |
| 102 | Hematochezia (HP:0002573) | 2.21665346 |
| 103 | Encephalitis (HP:0002383) | 2.21574612 |
| 104 | Glomerulopathy (HP:0100820) | 2.14828869 |
| 105 | Periodontitis (HP:0000704) | 2.14671072 |
| 106 | Acne (HP:0001061) | 2.12465054 |
| 107 | Skin ulcer (HP:0200042) | 2.11279598 |
| 108 | Chest pain (HP:0100749) | 2.10709506 |
| 109 | Restrictive lung disease (HP:0002091) | 2.10220273 |
| 110 | Agammaglobulinemia (HP:0004432) | 2.09373813 |
| 111 | Abnormality of the pericardium (HP:0001697) | 2.03759098 |
| 112 | Premature loss of primary teeth (HP:0006323) | 2.02721367 |
| 113 | Epistaxis (HP:0000421) | 1.99792086 |
| 114 | Urticaria (HP:0001025) | 1.99466609 |
| 115 | Hepatosplenomegaly (HP:0001433) | 1.98423485 |
| 116 | Hypertensive crisis (HP:0100735) | 1.97865927 |
| 117 | Abnormality of iron homeostasis (HP:0011031) | 1.97832899 |
| 118 | Recurrent sinusitis (HP:0011108) | 1.96623999 |
| 119 | Prolonged bleeding time (HP:0003010) | 1.94905614 |
| 120 | Arthralgia (HP:0002829) | 1.94399756 |
| 121 | Porencephaly (HP:0002132) | 1.91664392 |
| 122 | Pulmonary embolism (HP:0002204) | 1.88450357 |
| 123 | Colitis (HP:0002583) | 1.83724717 |
| 124 | Abnormality of the pleura (HP:0002103) | 1.81210995 |
| 125 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.80950958 |
| 126 | Impaired platelet aggregation (HP:0003540) | 1.80871308 |
| 127 | Abnormal platelet function (HP:0011869) | 1.80871308 |
| 128 | Osteomyelitis (HP:0002754) | 1.80795336 |
| 129 | Increased cerebral lipofuscin (HP:0011813) | 1.80427565 |
| 130 | Purpura (HP:0000979) | 1.79583265 |
| 131 | Persistence of primary teeth (HP:0006335) | 1.79411182 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.91430068 |
| 2 | TXK | 4.34833103 |
| 3 | TYK2 | 3.40489286 |
| 4 | JAK3 | 3.23403532 |
| 5 | IKBKE | 3.19715544 |
| 6 | FGFR4 | 2.98853402 |
| 7 | GRK7 | 2.97026252 |
| 8 | TBK1 | 2.96026792 |
| 9 | PRPF4B | 2.91800514 |
| 10 | TAOK2 | 2.88277541 |
| 11 | ZAP70 | 2.80524345 |
| 12 | MAP3K14 | 2.74170450 |
| 13 | RIPK1 | 2.42410427 |
| 14 | BLK | 2.39066403 |
| 15 | DDR2 | 2.38666332 |
| 16 | JAK1 | 2.26319899 |
| 17 | PIM2 | 2.13186007 |
| 18 | MATK | 2.05077009 |
| 19 | IKBKB | 1.99681210 |
| 20 | MAP3K10 | 1.97316782 |
| 21 | ERN1 | 1.90819089 |
| 22 | EEF2K | 1.89170406 |
| 23 | IRAK4 | 1.85865236 |
| 24 | KIT | 1.84663168 |
| 25 | FGFR3 | 1.71901360 |
| 26 | ITK | 1.67916276 |
| 27 | STK10 | 1.62065251 |
| 28 | GRK6 | 1.60602653 |
| 29 | MOS | 1.59971838 |
| 30 | CHUK | 1.59399318 |
| 31 | TESK2 | 1.56685976 |
| 32 | EPHB1 | 1.55882620 |
| 33 | RPS6KA4 | 1.54498234 |
| 34 | NLK | 1.47122813 |
| 35 | LCK | 1.46533490 |
| 36 | IRAK3 | 1.45610300 |
| 37 | SYK | 1.45074113 |
| 38 | EPHA3 | 1.41172042 |
| 39 | PIM1 | 1.40298193 |
| 40 | KDR | 1.37740191 |
| 41 | HCK | 1.36025287 |
| 42 | BTK | 1.32411156 |
| 43 | CDC42BPA | 1.32215402 |
| 44 | CSK | 1.21605931 |
| 45 | NME2 | 1.20377414 |
| 46 | FGR | 1.19865535 |
| 47 | BMPR2 | 1.18808800 |
| 48 | TRIB3 | 1.18676290 |
| 49 | MAP3K13 | 1.16773138 |
| 50 | TEC | 1.15179632 |
| 51 | SMG1 | 1.13960036 |
| 52 | RIPK4 | 1.07661316 |
| 53 | ADRBK2 | 1.00733056 |
| 54 | JAK2 | 0.98582677 |
| 55 | TYRO3 | 0.96545852 |
| 56 | LRRK2 | 0.95538333 |
| 57 | RPS6KA5 | 0.94749095 |
| 58 | MST4 | 0.94643568 |
| 59 | PKN2 | 0.89663697 |
| 60 | IRAK1 | 0.84988425 |
| 61 | CDK12 | 0.80907605 |
| 62 | LYN | 0.79327881 |
| 63 | MAP3K11 | 0.75658948 |
| 64 | MAP2K3 | 0.73526085 |
| 65 | TAOK1 | 0.71984490 |
| 66 | SIK2 | 0.70570102 |
| 67 | TAOK3 | 0.69423630 |
| 68 | MARK3 | 0.69195572 |
| 69 | CLK1 | 0.66967295 |
| 70 | SIK3 | 0.65659758 |
| 71 | STK4 | 0.61862385 |
| 72 | HIPK2 | 0.61222207 |
| 73 | TESK1 | 0.60380416 |
| 74 | ALK | 0.59819970 |
| 75 | RAF1 | 0.58380958 |
| 76 | FES | 0.58283696 |
| 77 | CDK4 | 0.58173349 |
| 78 | CSF1R | 0.57506950 |
| 79 | PBK | 0.55030171 |
| 80 | DYRK3 | 0.53761107 |
| 81 | PRKCQ | 0.52174423 |
| 82 | PRKCH | 0.52020063 |
| 83 | TGFBR2 | 0.51684034 |
| 84 | MAP3K8 | 0.51401964 |
| 85 | MAP3K5 | 0.51065840 |
| 86 | BMX | 0.50187394 |
| 87 | NEK2 | 0.49461077 |
| 88 | PTK6 | 0.45916752 |
| 89 | ICK | 0.45559232 |
| 90 | TLK1 | 0.45269818 |
| 91 | PKN1 | 0.44012155 |
| 92 | RPS6KB2 | 0.41997661 |
| 93 | RPS6KA1 | 0.40873420 |
| 94 | SIK1 | 0.40753786 |
| 95 | MAP3K3 | 0.40177453 |
| 96 | ABL1 | 0.40095068 |
| 97 | RPS6KC1 | 0.39804018 |
| 98 | RPS6KL1 | 0.39804018 |
| 99 | TNK2 | 0.38793044 |
| 100 | MAPKAPK2 | 0.38180261 |
| 101 | MAPK7 | 0.37821649 |
| 102 | ARAF | 0.36043550 |
| 103 | PDGFRA | 0.35983112 |
| 104 | ABL2 | 0.35662332 |
| 105 | MAP3K1 | 0.33493437 |
| 106 | MAPK11 | 0.33075495 |
| 107 | EIF2AK2 | 0.31887514 |
| 108 | DAPK3 | 0.31027406 |
| 109 | CDK6 | 0.30657528 |
| 110 | PDGFRB | 0.30622992 |
| 111 | LATS2 | 0.30575683 |
| 112 | EIF2AK1 | 0.30073160 |
| 113 | TGFBR1 | 0.29878635 |
| 114 | ACVR1B | 0.29365155 |
| 115 | TSSK6 | 0.29352052 |
| 116 | RPS6KA6 | 0.28836638 |
| 117 | CDK9 | 0.28277558 |
| 118 | MAP2K6 | 0.26515738 |
| 119 | EGFR | 0.24875645 |
| 120 | PRKCD | 0.22789346 |
| 121 | STK24 | 0.22438238 |
| 122 | INSR | 0.21618634 |
| 123 | PDK1 | 0.21613359 |
| 124 | NEK9 | 0.21395696 |
| 125 | MAPK4 | 0.19916932 |
| 126 | MAPK3 | 0.19078417 |
| 127 | BUB1 | 0.17857265 |
| 128 | MAP3K12 | 0.17525630 |
| 129 | IRAK2 | 0.16639519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.66962993 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.12637201 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.04473163 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.81483269 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.74064357 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.73184350 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.71865123 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.69908829 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.42086307 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.39844407 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.22727529 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.20746908 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.15141839 |
| 14 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.11975789 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.99305003 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.98863411 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.90288406 |
| 18 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.86258736 |
| 19 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.83998924 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.77608933 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.70624982 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.68822218 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.65261407 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.65208949 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.63156402 |
| 26 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.54502760 |
| 27 | Hepatitis B_Homo sapiens_hsa05161 | 1.49416260 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.46443134 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.44705133 |
| 30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.40319917 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.36726605 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.36057095 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.35729407 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.35411738 |
| 35 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.33704790 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.31724732 |
| 37 | Pertussis_Homo sapiens_hsa05133 | 1.31545049 |
| 38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.30759117 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30014517 |
| 40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.27071421 |
| 41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.18095802 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 1.11978162 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.05095761 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 1.03145890 |
| 45 | HTLV-I infection_Homo sapiens_hsa05166 | 1.02616234 |
| 46 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.02294529 |
| 47 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.02273636 |
| 48 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.00151242 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.93962213 |
| 50 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.92542969 |
| 51 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91579551 |
| 52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.86599267 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86546294 |
| 54 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86377756 |
| 55 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.80985081 |
| 56 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.79328879 |
| 57 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.74371455 |
| 58 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.72845002 |
| 59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71504906 |
| 60 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70575850 |
| 61 | Bladder cancer_Homo sapiens_hsa05219 | 0.68964698 |
| 62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68731100 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65570826 |
| 64 | Ribosome_Homo sapiens_hsa03010 | 0.64781617 |
| 65 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.63101341 |
| 66 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.62129084 |
| 67 | Platelet activation_Homo sapiens_hsa04611 | 0.61632606 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61554962 |
| 69 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58504444 |
| 70 | Proteasome_Homo sapiens_hsa03050 | 0.57623273 |
| 71 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57469836 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54371635 |
| 73 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54043318 |
| 74 | Spliceosome_Homo sapiens_hsa03040 | 0.51827743 |
| 75 | DNA replication_Homo sapiens_hsa03030 | 0.47238080 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 0.47013389 |
| 77 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43400481 |
| 78 | Base excision repair_Homo sapiens_hsa03410 | 0.41909426 |
| 79 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.40592430 |
| 80 | Amoebiasis_Homo sapiens_hsa05146 | 0.39915162 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39691853 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.39673622 |
| 83 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.36695103 |
| 84 | Other glycan degradation_Homo sapiens_hsa00511 | 0.36676059 |
| 85 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36421239 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36054220 |
| 87 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.35673127 |
| 88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33395882 |
| 89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.32062056 |
| 90 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.30556729 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.29259775 |
| 92 | Cell cycle_Homo sapiens_hsa04110 | 0.29194387 |
| 93 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29093930 |
| 94 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.29004716 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28085149 |
| 96 | Phagosome_Homo sapiens_hsa04145 | 0.28064111 |
| 97 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.27191490 |
| 98 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.27003828 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.26878747 |
| 100 | Prostate cancer_Homo sapiens_hsa05215 | 0.26694551 |
| 101 | * Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.25709456 |
| 102 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.25628798 |
| 103 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25358812 |
| 104 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.25304232 |
| 105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.24647782 |
| 106 | Pathways in cancer_Homo sapiens_hsa05200 | 0.23747277 |
| 107 | Thyroid cancer_Homo sapiens_hsa05216 | 0.22841081 |
| 108 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.22020456 |
| 109 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.20879907 |
| 110 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.19498433 |
| 111 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.18594811 |
| 112 | RNA degradation_Homo sapiens_hsa03018 | 0.17815116 |
| 113 | Galactose metabolism_Homo sapiens_hsa00052 | 0.17621463 |
| 114 | Endometrial cancer_Homo sapiens_hsa05213 | 0.16900933 |
| 115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.12059969 |
| 116 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.10690184 |
| 117 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.05372332 |
| 118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.00442571 |
| 119 | Vibrio cholerae infection_Homo sapiens_hsa05110 | -0.0188211 |

